30 October 2017
EFPIA Japan

Thorsten Poehl to become new Vice Chairman of EFPIA JapanTOKYO—30 October 2017— EFPIA Japan announced today that Thorsten Poehl(Chairman and Representative Director, Nippon Boehringer Ingelheim Co., Ltd.) has been
appointed the new Vice Chairman of EFPIA Japan effective 1 November 2017.
Together with Philippe Fauchet (GlaxoSmithKline K.K.), who continues to serve in his
position of vice chairmen, Thorsten Poehl will support Ole Mølskov Bech (Novo NordiskJapan Ltd.), the Chairman of EFPIA Japan, in his new role.
“EFPIA Japan engages in constructive dialogue with the government and otherstakeholders in order to help find the best possible solutions for Japanese physicians andpatients, and to support an effective healthcare system”, said Thorsten Poehl. “Weactively share experiences and best practices from Europe within Japan and contribute tothe policy debate.”

EFPIA Japan Board Members as of 1 November 2017
Newly appointed board members during this year are noted
ChairmanOle Mølskov Bech(Novo Nordisk Japan Ltd.)
Vice Chairmen
Philippe Fauchet (GlaxoSmithKline K.K.)
Thorsten Poehl (Nippon Boehringer Ingelheim Co., Ltd.)
Directors
Jacques Nathan (Sanofi K.K.)
Heike Prinz (Bayer Yakuhin, Ltd.)
Kazunari Tsunaba (Novartis Pharma K.K.)
Marc Dunoyer (AstraZeneca K.K.)
Leo Lee (Merck Serono Co., Ltd.)
Stefan Sakurai (LEO Pharma K.K.)
Director General
Simon Collier (EFPIA Japan)

New

New
New

__________________________________________________________________EFPIA Japan Office
Marunouchi Kitaguchi Bldg., 6-5, Marunouchi 1-chome, Chiyoda-ku, Tokyo 100-8265
Tel: +81-3-6301-3066 Fax: +81-3-6301-3060About EFPIA Japan:
Established in April 2002, EFPIA Japan represents 24 R&D-based European
pharmaceutical companies operating in Japan. In 2016, combined sales from the member
companies accounted for roughly 22% of the pharmaceutical market in Japan.
Mission of EFPIA Japan is to “Contribute to healthcare and patients in Japan by early
introduction of innovative medicines and vaccines”. EFPIA Japan aims to strengthen
dialogue with decision-makers in order to improve Japanese healthcare for all.
About EFPIA:EFPIA, EFPIA Japan’s partner organisation, is headquartered in Brussels and represents
the pharmaceutical industry operating in Europe. Through its direct membership of 33
national associations and 42 leading pharmaceutical companies, EFPIA provides thevoice of 1,900 companies committed to researching, developing and bringing newmedicines to improve health and quality of life around the world.
For more information please visit:
http://www.efpia.eu (EFPIA)
http://efpia.jp/English/index-e.html (EFPIA Japan)

Inquiries to:
Noriko Okazaki, Committee Chair, Public Relations Committee, EFPIA Japan
Novo Nordisk Pharma Ltd.
2-1-1 Marunouchi, Chiyoda-ku, Tokyo 100-0005
TEL: 080-3508-3251
Mail: no@novonordisk.com
Tetsu Owari, Committee Vice Chair, Public Relations Committee, EFPIA Japan
Boehringer Ingelheim Japan, Inc.
ThinkPark Tower 2-1-1 Osaki, Shinagawa-ku, Tokyo 141-6017
TEL: 03-6417-2223
Mail : tetsuya.owari@boehringer-ingelheim.com

2Personal profile

Thorsten Pöhl
Vice Chairman of EFPIA Japan
Current position:
President and Representative Director of Boehringer Ingelheim Japan, Inc.
Chairman and Representative Director of the following companies:- Nippon Boehringer Ingelheim Co., Ltd.
- Boehringer Ingelheim Vetmedica Japan Co., Ltd.
- Boehringer Ingelheim Seiyaku
Born in 1963, Norderney, Germany.
Graduated in 1992 from Westfälische Wilhelms Universität Münster, Germany with MBA.

Professional Experience:Jan 2017

Director of Merial Japan Limited

May 2016 President and Representative Director of Boehringer Ingelheim Japan, Inc.

2013

Chairman and Representative Director of the following companies:- Nippon Boehringer Ingelheim Co., Ltd.
- SSP Co., Ltd. (until December 2016)- Boehringer Ingelheim Vetmedica Japan Co., Ltd.
- Boehringer Ingelheim Seiyaku
President and CEO Boehringer Ingelheim España

2010

Senior Corporate Vice president, Talent Management, Boehringer Ingelheim GmbH2008

President and CEO Boehringer Ingelheim Mexico Promeco, S.A. de C.V.

2007

Head of Marketing & Sales Boehringer Ingelheim Mexico Promeco, S.A. de C.V.

2005

President and CEO Boehringer Ingelheim Norway KS

2001

President and CEO Boehringer Ingelheim del Ecuador Cia. Ltda.

1998

Regional Business Manager USA, Canada, Mexico Boehringer Ingelheim GmbH

1996

Regional Business Manager Brazil, Argentina, Chile, Boehringer Ingelheim GmbH

1993-1995 Product Line Manager, Product Manager, Medical Sales Representative,Boehringer Ingelheim do Brasil Quimíca e Farmacêutica Ltda.
1993

Joined Boehringer Ingelheim GmbH###3